Philip Leslie has more than 30 years’ pharmaceutical manufacturing experience in Australia, New Zealand and the UK, chiefly with GlaxoSmithKline, and also with MSD and Eli Lilly.
At GSK Australia, he ran the BFS production facility with a multi-disciplinary team of nearly 200 skilled people. He then led a team that designed, built and commissioned the world’s first commercially available BFS vaccine filling facility.
Also at GSK, Mr. Leslie helped oversee construction of a state-of-the-art solid dose facility that introduced one of the first electronic batch record systems with material and equipment tracking, and aided in the global rollout of an ERP system. Mr. Leslie co-created the Pharmaceutical Innovation Centre with Monash University, supported by the Victorian Government in Australia, which inducted him into its Manufacturing Hall of Fame in 2017 in recognition of his “outstanding contribution to manufacturing excellence in Victoria.”
